LEE S PHARMACEUTIC.HD-05
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and… Read more
Market Cap & Net Worth: LEE S PHARMACEUTIC.HD-05 (L1PA)
LEE S PHARMACEUTIC.HD-05 (F:L1PA) has a market capitalization of $82.20 Million (€80.08 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #22940 globally and #2499 in its home market, demonstrating a -3.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LEE S PHARMACEUTIC.HD-05's stock price €0.14 by its total outstanding shares 588835343 (588.84 Million).
LEE S PHARMACEUTIC.HD-05 Market Cap History: 2018 to 2026
LEE S PHARMACEUTIC.HD-05's market capitalization history from 2018 to 2026. Data shows change from $126.08 Million to $82.20 Million (-6.71% CAGR).
LEE S PHARMACEUTIC.HD-05 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LEE S PHARMACEUTIC.HD-05's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of L1PA by Market Capitalization
Companies near LEE S PHARMACEUTIC.HD-05 in the global market cap rankings as of March 19, 2026.
Key companies related to LEE S PHARMACEUTIC.HD-05 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
LEE S PHARMACEUTIC.HD-05 Historical Marketcap From 2018 to 2026
Between 2018 and today, LEE S PHARMACEUTIC.HD-05's market cap moved from $126.08 Million to $ 82.20 Million, with a yearly change of -6.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €82.20 Million | -13.92% |
| 2025 | €95.50 Million | -4.82% |
| 2024 | €100.33 Million | +26.43% |
| 2023 | €79.36 Million | +1.55% |
| 2022 | €78.15 Million | -35.22% |
| 2021 | €120.64 Million | -13.10% |
| 2020 | €138.84 Million | +11.61% |
| 2019 | €124.39 Million | -1.34% |
| 2018 | €126.08 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of LEE S PHARMACEUTIC.HD-05 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $82.20 Million USD |
| MoneyControl | $82.20 Million USD |
| MarketWatch | $82.20 Million USD |
| marketcap.company | $82.20 Million USD |
| Reuters | $82.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.